Contribution of functional KIR3DL1 to ankylosing spondylitis
- PMID: 20818412
- PMCID: PMC4002958
- DOI: 10.1038/cmi.2010.42
Contribution of functional KIR3DL1 to ankylosing spondylitis
Abstract
Increasing evidence points to a role for killer immunoglobulin-like receptors (KIRs) in the development of autoimmune diseases. In particular, a positive association of KIR3DS1 (activating receptor) and a negative association of KIR3DL1 (inhibitory receptor) alleles with ankylosing spondylitis (AS) have been reported by several groups. However, none of the studies analyzed these associations in the context of functionality of polymorphic KIR3DL1. To better understand how the KIR3DL1/3DS1 genes determine susceptibility to AS, we analyzed the frequencies of alleles and genotypes encoding functional (KIR3DL1*F) and non-functional (KIR3DL1*004) receptors. We genotyped 83 AS patients and 107 human leukocyte antigen (HLA)-B27-positive healthy controls from the Russian Caucasian population using a two-stage sequence-specific primer PCR, which distinguishes KIR3DS1, KIR3DL1*F and KIR3DL1*004 alleles. For the patients carrying two functional KIR3DL1 alleles, those alleles were additionally genotyped to identify KIR3DL1*005 and KIR3DL1*007 alleles, which are functional but are expressed at low levels. KIR3DL1 was negatively associated with AS at the expense of KIR3DL1*F but not of KIR3DL1*004. This finding indicates that the inhibitory KIR3DL1 receptor protects against the development of AS and is not simply a passive counterpart of the segregating KIR3DS1 allele encoding the activating receptor. However, analysis of genotype frequencies indicates that the presence of KIR3DS1 is a more important factor for AS susceptibility than the absence of KIR3DL1*F. The activation of either natural killer (NK) or T cells via the KIR3DS1 receptor can be one of the critical events in AS development, while the presence of the functional KIR3DL1 receptor has a protective effect. Nevertheless, even individuals with a genotype that carried two inhibitory KIR3DL1 alleles expressed at high levels could develop AS.
Comment in
-
Spondyloarthropathies: KIR status linked to susceptibility to ankylosing spondylitis.Nat Rev Rheumatol. 2010 Nov;6(11):614. doi: 10.1038/nrrheum.2010.170. Nat Rev Rheumatol. 2010. PMID: 21064239 No abstract available.
Similar articles
-
Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.Arthritis Rheum. 2010 Apr;62(4):1000-6. doi: 10.1002/art.27332. Arthritis Rheum. 2010. PMID: 20131260
-
Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.Arthritis Res Ther. 2006;8(4):R101. doi: 10.1186/ar1988. Arthritis Res Ther. 2006. PMID: 16805919 Free PMC article.
-
No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.Tissue Antigens. 2010 Jan;75(1):68-73. doi: 10.1111/j.1399-0039.2009.01392.x. Epub 2009 Oct 28. Tissue Antigens. 2010. PMID: 19874556
-
The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.Crit Rev Immunol. 2013;33(3):203-18. doi: 10.1615/critrevimmunol.2013007409. Crit Rev Immunol. 2013. PMID: 23756244 Free PMC article. Review.
-
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.Drug Dev Res. 2014 Nov;75 Suppl 1:S15-9. doi: 10.1002/ddr.21187. Drug Dev Res. 2014. PMID: 25381967 Review.
Cited by
-
The Genetics of Spondyloarthritis.J Pers Med. 2020 Oct 2;10(4):151. doi: 10.3390/jpm10040151. J Pers Med. 2020. PMID: 33023259 Free PMC article. Review.
-
Spondyloarthropathies: KIR status linked to susceptibility to ankylosing spondylitis.Nat Rev Rheumatol. 2010 Nov;6(11):614. doi: 10.1038/nrrheum.2010.170. Nat Rev Rheumatol. 2010. PMID: 21064239 No abstract available.
-
Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.PLoS Genet. 2020 Aug 17;16(8):e1008906. doi: 10.1371/journal.pgen.1008906. eCollection 2020 Aug. PLoS Genet. 2020. PMID: 32804949 Free PMC article.
-
Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis.Clin Exp Immunol. 2015 May;180(2):201-6. doi: 10.1111/cei.12568. Clin Exp Immunol. 2015. PMID: 25491925 Free PMC article. Clinical Trial.
-
An update on the genetics of HLA B27-associated acute anterior uveitis.Ocul Immunol Inflamm. 2011 Apr;19(2):108-14. doi: 10.3109/09273948.2011.559302. Ocul Immunol Inflamm. 2011. PMID: 21428748 Free PMC article. Review.
References
-
- Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904–907. - PubMed
-
- Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288:704–706. - PubMed
-
- Smith JA, Marker-Hermann E, Colbert RA. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol. 2006;20:571–591. - PubMed
-
- Bowness P. HLA B27 in health and disease: a double-edged sword. Rheumatology (Oxford) 2002;41:857–868. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials